J.P. Morgan Reinstates Underweight Rating on Myriad Over LT Outlook Concerns
March 31, 2014 at 10:41 AM EDT
J.P. Morgan analyst Tycho Peterson reinstated an Underweight rating and $25.00 price target on Myriad Genetics Inc. (NASDAQ: MYGN) ...
